LRRK2 and Alzheimer disease: Although previous studies have shown a correlation between nigral pathology and extrapyramidal symptoms in AD (Burns et al., 2005), our screening of 12 randomly selected AD cases did not reveal significant nigral cell loss, in contrast to the present LRRK2 case.